Oracle to provide platform to gauge malaria drug effectiveness vs. COVID-19
Oracle will provide a platform that will enable the US government to run clinical trials to see if two malaria drugs should be approved to treating COVID-19, according to sources close to the discussions. The New York Times reported that Oracle and the White House were in talks about the platform. ZDNet confirmed those talks.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063